FDA Panel Recommends EUA for Moderna Covid-19 Vaccine
Dec 18, 2020 FDA action expected within 24 hours or less For the second time this month, the FDA’s Vaccines and Related Biological Products Advisory Committee overwhelmingly voted to recommend that the FDA issue an Emergency Use Authorization (EUA) for a vaccine to combat SARS CoV-2 infection and thus end the Covid-19 pandemic. By a vote of 20 with one abstention, the VRBPAC members said “yes” to this question: “Based on the totality of scientific evidence available, do the benefits of the ModernaCOVID-19 Vaccine outweigh its risks for use in individuals 18 years of age and older?” ...